News
ONCOVITA and UNITHER Pharmaceuticals to develop new prophylactic vaccine based on Measovir and Euroject...
ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile...
Bristol Myers Squibb receives European Commission approval for Opdivo plus Yervoy for the first-line...
The European Commission (EC) has approved Bristol Myers Squibb's Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma...
Roche to collaborate with Zealand Pharma to co-develop and co-commercialise petrelintide for obesity
Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide, Zealand Pharma’s amylin analog as a...
